Invesco Dynamic Biotechnology & Genome ETF
PBE NYSE Arca
The Invesco Dynamic Biotechnology & Genome ETF is based on the Dynamic Biotech & Genome Intellidex℠ Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality,...
Hover to inspectDrag to measure a move← → to step through days
- Fund size
- 213M as of Feb 2020
- Expense ratio
- 0.58% per year
- Dividend yield
- 1.30% Quarterly
- Volatility · 1Y
- 19.9% Above Average
- Beta
- 0.74 vs the market
- 52-week range
- 72.60103.46
How PBE has paid off
Price return over every period, and total return with dividends reinvested, set against price alone.
Return by period
Price · to Oct 30Total return vs price return
Price onlyOver 1 year, PBE returned +41.2% with dividends reinvested — dividends added +1.8 pts to the price move.
How bumpy is the ride?
Return only means something next to the risk taken to earn it. Volatility, drawdowns and market sensitivity over 1 year.
Volatility
Annualized · 1YA typical year sees the price swing about ±20% around its trend.
Drawdown from peak
How far below its previous high the price has been Deepest fall −11.7% on Mar 27, 2026 — 79 days after the previous high
More than 5% below a high 22% of the time.
Market sensitivity
BetaA beta of 0.74 means PBE has moved less than the market.
Trend & momentum
Where the price sits against its moving averages, and how stretched the recent move is.
Price vs moving averages
Uptrend- 12-day average100.06 +2.4%
- 26-day average98.41 +4.2%
- 50-day average96.72 +6.0%
- 200-day average88.05 +16.4%
The price is above 4 of 4 averages. The 50-day average is above the 200-day, a sign of a rising longer-term trend.
Relative strength (RSI)
NeutralRSI compares recent gains with recent losses on a 0–100 scale. Above 70 a move is often considered stretched, below 30 washed out.
Technical indicators describe past prices. They are not a forecast.
Inside the fund
Health Care · Biotech — tracking the Dynamic Biotech & Genome Intellidex℠ Index.
- Assets under management213MUSD
- Expense ratio0.58%per year
- Holdings33
- Risk score5.5Medium
Launched June 2005. Fund data as of Feb 27, 2020.
What it pays you
Cash distributions over the last twelve months, and how they have grown.
About 13 USD a year for every 1,000 USD invested at today's price.
- Per share
- 1.33
- Frequency
- Quarterly
- Last paid
- Sep 21, 2026
Last 12 months
0.52 USD / shareWhere PBE shows up
Curated themes and indices that hold PBE. Open one to see it in context, or test the whole theme in a portfolio.
About Invesco Dynamic Biotechnology & Genome ETF
The Invesco Dynamic Biotechnology & Genome ETF is based on the Dynamic Biotech & Genome Intellidex℠ Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research
- Featured in 3 curated themes
- 33 holdings
- Ticker
- PBE
- Exchange
- NYSE Arca
- ISIN
- US46137V7872
- CUSIP
- 46137V787
- Currency
- U.S. Dollar (USD)
- Country
- USA
- Sector
- Health Care
- Industry
- Biotech
- Benchmark
- Dynamic Biotech & Genome Intellidex℠ Index
All key statistics
Details
Shareas of Oct 30, 2026
Dataas of Feb 27, 2020
Put PBE to the test
See how it would change the return and the risk of a portfolio, with virtual money, before a single real dollar moves.
Data for information only, not investment advice. Past performance does not guarantee future results.